ArticleJMIR research protocols2024

Effects of Empagliflozin in Type 2 Diabetes With and Without Chronic Kidney Disease and Nondiabetic Chronic Kidney Disease: Protocol for 3 Crossover Randomized Controlled Trials (SiRENA Project).

Steffen Flindt Nielsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.